Ruixian Chen
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Targeting THR-β for MASLD Treatment: Current Progression and Emerging Prospects.
Journal: Journal of medicinal chemistry
Published: January 06, 2026
Expanding indications for nanoparticle-assisted axillary staging in node-positive breast cancer after neoadjuvant therapy: a prospective cohort study.
Journal: International journal of surgery (London, England)
Published: September 03, 2025
Prediction model to prevent axillary surgery using axillary US and MRI in early breast cancer.
Journal: European radiology
Published: August 02, 2025
Aspirin Use and Risk of Breast Cancer Recurrence in Chinese Patients.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: May 27, 2025
Emerging opportunities to treat drug-resistant breast cancer: Discovery of novel small-molecule inhibitors against different targets.
Journal: Frontiers in pharmacology
Published: February 17, 2025
Targeting pattern recognition receptors for cancer therapy: Mechanisms and strategies.
Journal: Acta pharmaceutica Sinica. B
Published: October 17, 2024
Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects.
Journal: Journal of medicinal chemistry
Published: September 11, 2024
Unraveling the future: Innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy.
Journal: European journal of medicinal chemistry
Published: June 14, 2024
A nomogram for predicting breast cancer specific survival in elderly patients with breast cancer: a SEER population-based analysis.
Journal: BMC geriatrics
Published: October 07, 2022
Effect of adjuvant chemotherapy on the survival outcomes of elderly breast cancer: A retrospective cohort study based on SEER database.
Journal: Journal of evidence-based medicine
Published: September 07, 2022
Diagnostic value of core needle biopsy for determining HER2 status in breast cancer, especially in the HER2-low population.
Journal: Breast cancer research and treatment
Published: July 30, 2022
Last Updated: 09/26/2026